J. Dutré

CROHN’S DISEASE WHO FAILED BIOLOGIC THERAPIES: A NATIONAL COHORT STUDY

M. Vos, S. Vermeire, E. Louis, 2020 .

Long-term clinical effectiveness of ustekinumab in patients with Crohn's disease who failed biological therapies: a national cohort study.

D. Franchimont, S. Vermeire, E. Louis, 2019, Journal of Crohn's & colitis.

Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort.

O. Dewit, D. Franchimont, E. Louis, 2018, Inflammatory bowel diseases.

A novel hypomorphic mutation in STIM1 results in a late-onset immunodeficiency.

A. Fischer, C. Picard, C. Lenoir, 2015, The Journal of allergy and clinical immunology.

The use of the double-balloon enteroscope for endoscopic retrograde cholangiopancreatography and biliary stent placement after Roux-en-Y hepaticojejunostomy.

P. Parizel, T. Moreels, P. Pelckmans, 2007, Endoscopy.

Clostridium perfringens splenic abscess treated with percutaneous drainage and antibiotic therapy: a case report

I. Demedts, H. Mertes, J. Dutré, 2021, Acta Clinica Belgica.

Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus.

E. Van Cutsem, M. Ferrante, F. Baert, 2023, European journal of cancer.

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.

A. Gasbarrini, B. Sands, I. Lawrance, 2023, Gastroenterology.